Perlmutter, A <br/><br/>
Tuberculosis and tumour necrosis factor-alpha inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians.  [electronic resource] 

 -  The British journal of dermatology  Jan 2009 
 - 8-15 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Review 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2133.2008.08891.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Arthritis, Psoriatic--drug therapy<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Immunosuppressive Agents--adverse effects<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Practice Guidelines as Topic<br/>Psoriasis--drug therapy<br/>Receptors, Tumor Necrosis Factor--antagonists & inhibitors<br/>Risk Factors<br/>Tuberculosis--chemically induced<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors